Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NEO-ADIXERN: Neoadjuvant Ixabepilone in Breast Cancer
NCT00751868Phase 2Completed
- Sponsor
- Consorzio Oncotech
- Start
- Sep 2008
- Primary completion
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ixabepilone in breast cancer, sponsored by Consorzio Oncotech. Primary endpoint: Pathologic Complete Response at 1 year. Started Sep 2008; status: completed.
02
Drugs
ixabepilone
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00751868.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00751868.